NasdaqCM - Delayed Quote USD

Atossa Therapeutics, Inc. (ATOS)

1.5400

+0.0800

(+5.48%)

At close: May 14 at 4:00 PM EDT

1.5600

+0.02

(+1.30%)

After hours: May 14 at 7:49 PM EDT

Key Events

Loading Chart for ATOS

9/21 12:03 PM

DELL

Previous Close 1.4600
Open 1.4300
Bid 1.5500 x 800
Ask 1.5800 x 1000
Day's Range 1.4100 - 1.5850
52 Week Range 0.6200 - 2.3100
Volume 1,429,464
Avg. Volume 1,924,049
Market Cap (intraday) 193.282M
Beta (5Y Monthly) --
PE Ratio (TTM) --
EPS (TTM) -0.2400
Earnings Date Aug 12, 2024 - Aug 16, 2024
Forward Dividend & Yield --
Ex-Dividend Date --
1y Target Est 5.33

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines in the areas of unmet medical need in oncology for women breast cancer and other conditions in the United States. The company's lead drug candidate is oral (Z)-endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It also develops immunotherapy/chimeric antigen receptor therapy programs. The company was formerly known as Atossa Genetics Inc. and changed its name to Atossa Therapeutics, Inc. in January 2020. Atossa Therapeutics, Inc. was founded in 2008 and is headquartered in Seattle, Washington.

www.atossatherapeutics.com

12

Full Time Employees

December 31

Fiscal Year Ends

Sector

Industry

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

ATOS

75.00%

S&P 500

10.00%

1-Year Return

ATOS

120.00%

S&P 500

27.22%

3-Year Return

ATOS

34.75%

S&P 500

27.58%

5-Year Return

ATOS

38.89%

S&P 500

86.59%

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Atossa Therapeutics, Inc.

1.5400

+5.48%

Mkt Cap 193.282M

Industry Biotechnology

SELLAS Life Sciences Group, Inc.

1.3700

0.00%

Mkt Cap 79.124M

Industry Biotechnology

Tonix Pharmaceuticals Holding Corp.

0.1800

+5.20%

Mkt Cap 17.198M

Industry Biotechnology

1.7000

-6.08%

Mkt Cap 465.764M

Industry Biotechnology

Citius Pharmaceuticals, Inc.

0.6876

-1.11%

Mkt Cap 125.518M

Industry Biotechnology

Jaguar Health, Inc.

0.2749

-5.30%

Mkt Cap 83.525M

Industry Biotechnology

Akebia Therapeutics, Inc.

1.2300

-4.65%

Mkt Cap 270.38M

Industry Biotechnology

0.8647

+5.45%

Mkt Cap 152.912M

Industry Biotechnology

Candel Therapeutics, Inc.

10.70

+4.90%

Mkt Cap 314.018M

Industry Biotechnology

Reviva Pharmaceuticals Holdings, Inc.

1.8250

+7.35%

Mkt Cap 50.951M

Industry Biotechnology

NRx Pharmaceuticals, Inc.

3.1800

+6.35%

Mkt Cap 33.566M

Industry Biotechnology

Valuation Measures

As of 5/13/2024

Market Cap

184.20M
Enterprise Value

95.74M
Trailing P/E

--
Forward P/E

--
PEG Ratio (5yr expected)

--
Price/Sales (ttm)

--
Price/Book (mrq)

2.02
Enterprise Value/Revenue

--
Enterprise Value/EBITDA

--

Financial Highlights

Profitability and Income Statement

Profit Margin

0.00%
Return on Assets (ttm)

-18.85%
Return on Equity (ttm)

-29.84%
Revenue (ttm)

--
Net Income Avi to Common (ttm)

-29.69M
Diluted EPS (ttm)

-0.2400

Balance Sheet and Cash Flow

Total Cash (mrq)

83.96M
Total Debt/Equity (mrq)

--
Levered Free Cash Flow (ttm)

-8.62M

ATOS does not have Company Insights

JAGX Jaguar Health, Inc.

0.2749

-5.30%

TNXP Tonix Pharmaceuticals Holding Corp.

0.1800

+5.20%

OCGN Ocugen, Inc.

1.7000

-6.08%

SENS Senseonics Holdings, Inc.

0.4899

+10.29%

CTRM Castor Maritime Inc.

3.7200

-3.38%

BIOL BIOLASE, Inc.

0.1540

-14.87%

ZOM Zomedica Corp.

0.1461

+4.58%

ACST Acasti Pharma Inc.

2.7900

+0.72%

CTXR Citius Pharmaceuticals, Inc.

0.6876

-1.11%

TTOO T2 Biosystems, Inc.

4.1600

-5.24%

AVGR Avinger, Inc.

3.8500

-2.04%

BNGO Bionano Genomics, Inc.

1.1100

+7.77%

OGEN Oragenics, Inc.

1.6500

+10.00%

XELA Exela Technologies, Inc.

2.8900

+9.06%

GEVO Gevo, Inc.

0.7289

+0.72%

ITRM Iterum Therapeutics plc

1.5000

-1.32%